BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2265 related articles for article (PubMed ID: 34181102)

  • 1. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
    Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
    Elife; 2023 Mar; 12():. PubMed ID: 36947108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
    Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
    Elife; 2023 May; 12():. PubMed ID: 37233729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long COVID in pediatrics-epidemiology, diagnosis, and management.
    Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
    Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
    Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
    Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
    Knopman DS; Laskowitz DT; Koltai DC; Charvet LE; Becker JH; Federman AD; Wisnivesky J; Mahncke H; Van Vleet TM; Bateman L; Kim DY; O'Steen A; James M; Silverstein A; Lokhnygina Y; Rich J; Feger BJ; Zimmerman KO
    Trials; 2024 May; 25(1):326. PubMed ID: 38755688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
    Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
    Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
    Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
    J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Respiratory Post-Acute Sequelae of COVID-19 (PASC) and the Potential Benefits of Pulmonary Rehabilitation.
    Simon M; Simmons JE
    R I Med J (2013); 2022 Sep; 105(7):11-15. PubMed ID: 35930484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
    Leung JM; Wu MJ; Kheradpour P; Chen C; Drake KA; Tong G; Ridaura VK; Zisser HC; Conrad WA; Hudson N; Allen J; Welberry C; Parsy-Kowalska C; Macdonald I; Tapson VF; Moy JN; deFilippi CR; Rosas IO; Basit M; Krishnan JA; Parthasarathy S; Prabhakar BS; Salvatore M; Kim CC
    Front Immunol; 2024; 15():1348041. PubMed ID: 38318183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.
    Proal AD; VanElzakker MB
    Front Microbiol; 2021; 12():698169. PubMed ID: 34248921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral persistence, reactivation, and mechanisms of long COVID.
    Chen B; Julg B; Mohandas S; Bradfute SB;
    Elife; 2023 May; 12():. PubMed ID: 37140960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative.
    L Mandel H; Colleen G; Abedian S; Ammar N; Charles Bailey L; Bennett TD; Daniel Brannock M; Brosnahan SB; Chen Y; Chute CG; Divers J; Evans MD; Haendel M; Hall MA; Hirabayashi K; Hornig M; Katz SD; Krieger AC; Loomba J; Lorman V; Mazzotti DR; McMurry J; Moffitt RA; Pajor NM; Pfaff E; Radwell J; Razzaghi H; Redline S; Seibert E; Sekar A; Sharma S; Thaweethai T; Weiner MG; Jae Yoo Y; Zhou A; Thorpe LE
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37166330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postacute Sequelae of SARS-CoV-2 in Children.
    Rao S; Gross RS; Mohandas S; Stein CR; Case A; Dreyer B; Pajor NM; Bunnell HT; Warburton D; Berg E; Overdevest JB; Gorelik M; Milner J; Saxena S; Jhaveri R; Wood JC; Rhee KE; Letts R; Maughan C; Guthe N; Castro-Baucom L; Stockwell MS
    Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38321938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
    Williams GP; Yu ED; Shapiro K; Wang E; Freuchet A; Frazier A; Lindestam Arlehamn CS; Sette A; da Silva Antunes R
    Hum Immunol; 2024 May; 85(3):110770. PubMed ID: 38433036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 114.